Howard C, Johnson W, Pervin S, Izevbigie E
Botanics. 2016; 5:65-76.
PMID: 27226742
PMC: 4876981.
DOI: 10.2147/BTAT.S62984.
Faustino-Rocha A, Gama A, Oliveira P, Alvarado A, Neuparth M, Ferreira R
Clin Exp Med. 2016; 17(2):151-160.
PMID: 27094311
DOI: 10.1007/s10238-016-0419-0.
Bayraktar S, Qiu H, Liu D, Shen Y, Gutierrez-Barrera A, Arun B
Biomark Cancer. 2015; 7:39-49.
PMID: 26327783
PMC: 4541461.
DOI: 10.4137/BIC.S29716.
Sangma M, Panda K, Dasiah S
J Clin Diagn Res. 2013; 7(3):503-6.
PMID: 23634406
PMC: 3616566.
DOI: 10.7860/JCDR/2013/5355.2807.
Talma H, Schonbeck Y, van Dommelen P, Bakker B, van Buuren S, Hirasing R
PLoS One. 2013; 8(4):e60056.
PMID: 23579990
PMC: 3620272.
DOI: 10.1371/journal.pone.0060056.
Serum oestradiol in women with carcinomas of the breast and uterine cervix.
Ray A, Bahadur A, Dayalu Naik S, Sharma B
Indian J Clin Biochem. 2012; 16(2):199-202.
PMID: 23105318
PMC: 3453627.
DOI: 10.1007/BF02864861.
Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation.
Sotgia F, Casimiro M, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O
Am J Pathol. 2009; 174(2):613-29.
PMID: 19164602
PMC: 2630569.
DOI: 10.2353/ajpath.2009.080653.
Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.
Brandt-Rauf S, Raveis V, Drummond N, Conte J, Rothman S
Am J Public Health. 2006; 96(11):1979-88.
PMID: 17018815
PMC: 1751808.
DOI: 10.2105/AJPH.2005.083014.
Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians.
Claus E
Fam Cancer. 2003; 1(3-4):197-206.
PMID: 14574179
DOI: 10.1023/a:1021135807900.
Rating the risk factors for breast cancer.
Singletary S
Ann Surg. 2003; 237(4):474-82.
PMID: 12677142
PMC: 1514477.
DOI: 10.1097/01.SLA.0000059969.64262.87.
Hormonal regulation of mammary differentiation and milk secretion.
Neville M, McFadden T, Forsyth I
J Mammary Gland Biol Neoplasia. 2002; 7(1):49-66.
PMID: 12160086
DOI: 10.1023/a:1015770423167.
Lactation and breast cancer risk.
Newcomb P
J Mammary Gland Biol Neoplasia. 1997; 2(3):311-8.
PMID: 10882314
DOI: 10.1023/a:1026344707161.
Is there a reduced risk of breast cancer among women with hip fractures?.
Ganry O, Peng J, Dubreuil A
Eur J Epidemiol. 1999; 15(4):313-5.
PMID: 10414370
DOI: 10.1023/a:1007579112855.
Rethinking breast cancer risk and the environment: the case for the precautionary principle.
Davis D, Axelrod D, Bailey L, Gaynor M, Sasco A
Environ Health Perspect. 1998; 106(9):523-9.
PMID: 9721252
PMC: 1533169.
DOI: 10.1289/ehp.98106523.
Breast cancer risk and lifetime occupational history: employment in professional and managerial occupations.
Petralia S, Vena J, Freudenheim J, Marshall J, Michalek A, Brasure J
Occup Environ Med. 1998; 55(1):43-8.
PMID: 9536162
PMC: 1757502.
DOI: 10.1136/oem.55.1.43.
Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky counties.
Kettles M, Browning S, Prince T, HORSTMAN S
Environ Health Perspect. 1998; 105(11):1222-7.
PMID: 9370519
PMC: 1470339.
DOI: 10.1289/ehp.971051222.
Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.
Toniolo P
Environ Health Perspect. 1997; 105 Suppl 3:587-92.
PMID: 9168000
PMC: 1469902.
DOI: 10.1289/ehp.97105s3587.
Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.
Willis D, Calle E, Heath Jr C
Cancer Causes Control. 1996; 7(4):449-57.
PMID: 8813433
DOI: 10.1007/BF00052671.
Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research.
Zahm S, Fraumeni Jr J
Environ Health Perspect. 1995; 103 Suppl 8:283-6.
PMID: 8741799
PMC: 1518973.
DOI: 10.1289/ehp.95103s8283.
Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk (New York, United States).
Ambrosone C, Marshall J, Vena J, Laughlin R, Graham S, Nemoto T
Cancer Causes Control. 1995; 6(5):407-15.
PMID: 8547538
DOI: 10.1007/BF00052180.
